Literature DB >> 22081904

Rational design of stereoselectivity in the class II pyruvate aldolase BphI.

Perrin Baker1, Stephen Y K Seah.   

Abstract

BphI, a pyruvate-specific class II aldolase, catalyzes the reversible carbon-carbon bond formation of 4-hydroxy-2-oxoacids up to eight carbons in length. During the aldol addition catalyzed by BphI, the S-configured stereogenic center at C4 is created via attack of a pyruvate enolate intermediate on the si face of the aldehyde carbonyl of acetaldehyde to form 4(S)-hydroxy-2-oxopentanoate. Replacement of a Leu-87 residue within the active site of the enzyme with polar asparagine and bulky tryptophan led to enzymes with no detectable aldolase activity. These variants retained decarboxylase activity for the smaller oxaloacetate substrate, which is not inhibited by excess 4-hydroxy-2-oxopentanoate, confirming the results from molecular modeling that Leu-87 interacts with the C4-methyl of 4(S)-hydroxy-2-oxoacids. Double variants L87N;Y290F and L87W;Y290F were constructed to enable the binding of 4(R)-hydroxy-2-oxoacids by relieving the steric hindrance between the 5-methyl group of these compounds and the hydroxyl substituent on the phenyl ring of Tyr-290. The resultant enzymes were shown to exclusively utilize only 4(R)- and not 4(S)-hydroxy-2-oxopentanoate as the substrate. Polarimetric analysis confirmed that the double variants are able to synthesize 4-hydroxy-2-oxoacids up to eight carbons in length, which were the opposite stereoisomer compared to those produced by the wild-type enzyme. Overall the k(cat)/K(m) values for pyruvate and aldehydes in the aldol addition reactions were affected ≤10-fold in the double variants relative to the wild-type enzyme. Thus, stereocomplementary class II pyruvate aldolases are now available to create chiral 4-hydroxy-2-oxoacid skeletons as synthons for organic reactions.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22081904     DOI: 10.1021/ja208754r

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  8 in total

1.  Binding and channeling of alternative substrates in the enzyme DmpFG: a molecular dynamics study.

Authors:  Natalie E Smith; Alice Vrielink; Paul V Attwood; Ben Corry
Journal:  Biophys J       Date:  2014-04-15       Impact factor: 4.033

Review 2.  DHAP-dependent aldolases from (hyper)thermophiles: biochemistry and applications.

Authors:  Pierpaolo Falcicchio; Suzanne Wolterink-Van Loo; Maurice C R Franssen; John van der Oost
Journal:  Extremophiles       Date:  2013-10-29       Impact factor: 2.395

Review 3.  Rational approaches for engineering novel functionalities in carbon-carbon bond forming enzymes.

Authors:  Perrin Baker; Stephen Y K Seah
Journal:  Comput Struct Biotechnol J       Date:  2012-10-02       Impact factor: 7.271

Review 4.  Computational tools for rational protein engineering of aldolases.

Authors:  Michael Widmann; Jürgen Pleiss; Anne K Samland
Journal:  Comput Struct Biotechnol J       Date:  2012-11-13       Impact factor: 7.271

Review 5.  Engineering aldolases as biocatalysts.

Authors:  Claire L Windle; Marion Müller; Adam Nelson; Alan Berry
Journal:  Curr Opin Chem Biol       Date:  2014-01-04       Impact factor: 8.822

6.  Redesigning Aldolase Stereoselectivity by Homologous Grafting.

Authors:  Carolin Bisterfeld; Thomas Classen; Irene Küberl; Birgit Henßen; Alexander Metz; Holger Gohlke; Jörg Pietruszka
Journal:  PLoS One       Date:  2016-06-21       Impact factor: 3.240

Review 7.  Building Bridges: Biocatalytic C-C-Bond Formation toward Multifunctional Products.

Authors:  Nina G Schmidt; Elisabeth Eger; Wolfgang Kroutil
Journal:  ACS Catal       Date:  2016-06-08       Impact factor: 13.084

8.  Structurally Informed Mutagenesis of a Stereochemically Promiscuous Aldolase Produces Mutants That Catalyze the Diastereoselective Syntheses of All Four Stereoisomers of 3-Deoxy-hexulosonic Acid.

Authors:  Sylvain F Royer; Xuan Gao; Robin R Groleau; Marc W van der Kamp; Steven D Bull; Michael J Danson; Susan J Crennell
Journal:  ACS Catal       Date:  2022-09-06       Impact factor: 13.700

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.